If you have trouble reading this email,
go to custom URL

Glaucoma Newsletter

GE Healthcare Financial Services

Sponsored by GE Healthcare Financial Services
GE Healthcare Financial Services
Financial solutions to take you through all stages of your practice’s growth. GE Healthcare Financial Services offers products for practice start-ups or expansion, for equipment financing and practice acquisitions. We provide a nationwide network of financing experts dedicated to the needs of Eye Care professionals. Our experts will guide you through our suite of flexible financial solutions to best meet the needs of you and your practice.

Special offer for customers of OphthalmologyWeb and Medcompare: When you finance with GE Healthcare Financial Services, we’ll waive all fees for you (a value of up to $350). Read more…


In this Newsletter
Technology Spotlight
News
New Products
Featured Products
Journal Updates
Events

On OphthalmologyWeb.com
Forums
CME Search
Drug Guide
 
Technology Spotlight View More Technology Spotlights
Implantable Posterior Segment Drug Delivery Devices
Implantable Posterior Segment Drug Delivery Devices
Intravitreal implants offer long-term pharmacotherapeutic exposure to the posterior segment. This has several obvious advantages, not the least of which is the fact that it removes the problem of patient adherence and compliance with topical drug regimens. The disadvantages include the inherent risks with implantation of these various devices (endophthalmitis, retinal detachment, inflammation, or cataract) as well as the fact that, once implanted, surgical explantation may be necessary to reduce the effects of some of the serious side-effects of these devices in rare circumstances. This article reviews the current status of various posterior segment intraocular drug delivery devices, both approved and in clinical development. more…
News View More News
Optic Nerve Physician Resource Center Unveiled
The development of an optic nerve physician resource center, in conjunction with the “All Eyes on Glaucoma” campaign, was announced during the Association for Research in Vision and Ophthalmology more…

NicOx Shares Fall Most In 5 Years On Study Failure
May 6 (Bloomberg) -- NicOx SA, the French drugmaker developing treatments with Pfizer Inc. and Merck & Co., fell the most in five years in Paris trading after an experimental glaucoma medicine failed more…

NicOx Announces U.S. Phase 2a Results For PF-03187207 And Gives An Update On Continuing NO-Prostaglandin Program
NicOx S.A. (Euronext Paris: COX) today announced the results of a U.S. phase 2 study, conducted by its partner Pfizer Inc, which compared the safety and efficacy of various doses of PF-03187207 to more…

OPKO Health Acquires Company Developing Novel Glaucoma Therapy
OPKO Health, Inc. (Amex: OPK) today announced that it has acquired Vidus Ocular, Inc., a privately held company that is developing Aquashunt(TM), an innovative shunt to treat glaucoma, the second more…

Statins Linked With Neuroprotection
Statin drugs could act as a neuroprotective agent for glaucoma suspect patients, preventing progression of optic nerve head parameters, a study found. Shan C. Lin, MD, and colleagues conducted more…

Optos Device Supports Scientists In Gene Therapy Research
Optos plc (LSE: OPTS), a leading medical technology company for the design, development, manufacturing and marketing of retinal imaging devices, is today announcing that its P200 device has supported more…

New Test For Peak IOP Is Faster, Easier, Researcher Says
FORT LAUDERDALE, Fla. — A 5-minute provocative test that inverts a patient's body 30° is as good as a standard water drinking test in detecting peak IOP in glaucoma patients, according to a poster more…

New Products View More New Products
BD Visitec™ Disposable Instruments
BD Visitec™ Disposable Instruments
BD Ophthalmics
Ophthalmic Systems is proud to introduce a family of disposable stainless steel instruments for ophthalmic surgery, continuing a more than 70-year tradition of innovation, safety and unparalleled quality.

The BD Visitec™ Disposable Instruments have been designed with safety convenience and precision in mind to reduce the risk of infection. more…

Featured Products  
RTVue-100 Fourier-Domain Optical Coherence Tomography (OCT) - Optovue Corporation  more…

EyeRoute™ Ophthalmic Image Management System  - Topcon America Corporation more…

Pulsair EasyEye Handheld Non-Contact Tonometer  - Keeler Instruments Inc. more…

Low Contrast Flip Chart Recording Pad - Richmond Products, Inc. more…

BD Beaver™ Accurate Depth Knives - BD Ophthalmics more…

Journal Updates View More Journal Updates
Discriminating between Normal and Glaucoma-Damaged Eyes with the Heidelberg Retina Tomograph 3
more…

Contribution of CYP1B1 Mutations and Founder Effect to Primary Congenital Glaucoma in Mexico
more…

Three-dimensional Anterior Segment Optical Coherence Tomography of Filtering Blebs After Trabeculectomy
more…

Evaluation of a Modified Protocol for Selective Laser Trabeculoplasty
more…

Cerebrospinal Fluid Pressure Is Decreased in Primary Open-angle Glaucoma
more…

Comparison of Gonioscopy and Anterior Segment Ocular Coherence Tomography in Detecting Angle Closure in Different Quadrants of the Anterior Chamber Angle
more…

Events View More Events
World Ophthalmology Congress 2008
June 28 - July 2, 2008
Hong Kong
The leadership and organization for the 28 specialties and subspecialties will be provided by a Who's Who of international leaders in ophthalmology as our scientific coordinators.These internationally respected leaders are recruiting outstanding moderators and chairs and, together, they ensure that we will have the best speakers from around the world.
more…

^ top

Copyright © OphthalmologyWeb, 2007-2008. All rights reserved.

This newsletter was sent to: mmclean@medcompare.com
To unsubscribe, please visit OphthalmologyWeb.com to change or remove your subscriptions.

www.ophthalmologyweb.com
395 Oyster Point Blvd., Suite 330
South San Francisco, CA 94080